• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis.

作者信息

Koshy A, Hadengue A, Lee S S, Jiron M I, Lebrec D

出版信息

Clin Pharmacol Ther. 1987 Sep;42(3):295-8. doi: 10.1038/clpt.1987.150.

DOI:10.1038/clpt.1987.150
PMID:3621783
Abstract

The acute effects of nifedipine, 10 mg administered sublingually, were studied in 10 patients with alcoholic cirrhosis. Nifedipine significantly increased cardiac output and reduced systemic vascular resistance. Nifedipine also increased the hepatic venous pressure gradient by 15% (P less than 0.01). Hepatic blood flow and azygos blood flow did not change significantly. It is suggested that nifedipine increases portal pressure and thus may be deleterious to patients with portal hypertension.

摘要

相似文献

1
Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis.
Clin Pharmacol Ther. 1987 Sep;42(3):295-8. doi: 10.1038/clpt.1987.150.
2
Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.硝酸异山梨酯对酒精性肝硬化门静脉高压的影响。
J Hepatol. 1987 Apr;4(2):174-80. doi: 10.1016/s0168-8278(87)80077-6.
3
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].[特利加压素单独或联合硝酸甘油给药对肝硬化患者的血流动力学影响]
Gastroenterol Clin Biol. 1992;16(8-9):680-6.
4
Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.特利加压素对肝硬化患者全身、肝脏和肾脏血流动力学的影响。
J Gastroenterol Hepatol. 2009 Nov;24(11):1791-7. doi: 10.1111/j.1440-1746.2009.05873.x. Epub 2009 Aug 3.
5
The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.普萘洛尔对肝硬化患者门静脉高压的影响:一项血流动力学研究。
Hepatology. 1982 Sep-Oct;2(5):523-7. doi: 10.1002/hep.1840020502.
6
Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.α/β受体阻滞剂卡维地洛对肝硬化门静脉高压患者肝脏及全身血流动力学的影响。
Arzneimittelforschung. 1997 Apr;47(4):353-5.
7
The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.钙通道阻滞剂维拉帕米并不能改善酒精性肝硬化患者的门静脉压力。
Br J Clin Pharmacol. 1988 Sep;26(3):273-7. doi: 10.1111/j.1365-2125.1988.tb05277.x.
8
Portal hemodynamics during nitroglycerin administration in cirrhotic patients.肝硬化患者使用硝酸甘油期间的门静脉血流动力学
Hepatology. 1987 Sep-Oct;7(5):805-9. doi: 10.1002/hep.1840070502.
9
Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.生长抑素对肝硬化患者肝脏及全身血流动力学的影响:与血管加压素的比较。
Gastroenterology. 1981 Mar;80(3):518-25.
10
Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension.奥曲肽可预防门静脉高压症患者餐后内脏充血。
J Hepatol. 1994 Jul;21(1):88-94. doi: 10.1016/s0168-8278(94)80142-8.

引用本文的文献

1
Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: role of prostaglandin.维拉帕米对门静脉结扎大鼠模型中一氧化氮合酶的影响:前列腺素的作用
World J Gastroenterol. 2006 Apr 21;12(15):2351-6. doi: 10.3748/wjg.v12.i15.2351.
2
Drug administration in chronic liver disease.慢性肝病中的药物给药
Drug Saf. 1997 Jul;17(1):47-73. doi: 10.2165/00002018-199717010-00004.
3
Intravenous nicardipine does not alter hepatic blood flow after orthotopic liver transplant.
Intensive Care Med. 1996 May;22(5):420-5. doi: 10.1007/BF01712158.
4
Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration.尼索地平:静脉及口服给药后对肝硬化患者血压和心率的动力学及影响
Eur J Clin Pharmacol. 1988;34(4):387-94. doi: 10.1007/BF00542441.